Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market.
Scheinberg, Morton Aaron; Felix, Paulo Antonio Oldani; Kos, Igor Age; Andrade, Maurício De Angelo; Azevedo, Valderilio Feijó.
Einstein (Sao Paulo)
; 16(3): eRW4175, 2018 Sep 17.
Artigo em Inglês, Português | MEDLINE | ID: mdl-30231147
The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC)
The process defines the product: what really matters in biosimilar design and production?
An overview of biosimilars and non-biologic complex drugs in Europe, the United States, and Canada and their relevance to multiple sclerosis.
Biosimilars: where we were and where we are.
Billigare med biosimilarer - men säkerheten går först.
A Comprehensive Overview on Biosimilars.
Biosimilars: Hope and concern.
Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a point of view.
Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use.
Biosimilars take center stage.